Tech Company Financing Transactions

CytoVale Funding Round

On 10/31/2019, CytoVale received $15 million in Series B funding from Blackhorn Ventures, Breakout Capital and Western Technology Investment.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

150 Executive Park Blvd. 4100
San Francisco, CA 94134
USA

Phone

Undisclosed

Website

www.cytovale.com

Email Address

[email protected]

Overview

We're inspired by the power of biology and driven to build tools that make it possible to access that power in new ways.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ajay Shah

        

Chief Operating Officer

Jennifer Beedon

        

VP - Engineering

Henry Tse

        

Browse more venture capital transactions:

Prev: 10/31/2019: MIRROR venture capital transaction
Next: 10/31/2019: Vacasa venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary